We would like to acknowledge the extraordinary contributions of the late Dr Iris Depaz, a finalist in the Life Sciences Queensland Ltd (LSQ) GENE Awards for the QIMR Berghofer Medical Research Institute Woman of Influence Award. As Sanofi's Head of Medical Vaccines, ANZ and South Korea, and Managing Director of the Translational Science Hub (TSH), Dr Depaz has been a champion for the biotech sector and integral in leading Queensland's development of mRNA vaccine technology. The GENE Awards recognise excellence and achievement in Queensland's life sciences sector. Winners will be announced tomorrow. About the LSQ GENE Awards: https://lnkd.in/gCb98cPX
Translational Research Institute Australia
Research
Woolloongabba, QLD 13,176 followers
An Australian-first bench-to-bedside medical research institute, translating medical discoveries into improved health.
About us
The TRI is a medical research institute based in Brisbane, Australia, interfacing directly with hospital clinicians, government and industry to improve the success of scientific discoveries translated into real treatments and diagnostics for improved health outcomes.
- Website
-
http://www.tri.edu.au
External link for Translational Research Institute Australia
- Industry
- Research
- Company size
- 501-1,000 employees
- Headquarters
- Woolloongabba, QLD
- Type
- Nonprofit
- Founded
- 2012
- Specialties
- medical research, teaching, cervical cancer, breast cancer, prostate cancer, melanoma, liver and kidney disease, osteoporosis, obesity, diabetes, immunology, and immunotherapy
Locations
-
Primary
37 Kent Street
Woolloongabba, QLD 4102, AU
Employees at Translational Research Institute Australia
Updates
-
TRI is pleased to have welcomed Federal Minister for Industry and Science Ed Husic MP today. Thank you to Microba Life Sciences and Life Sciences Queensland Ltd (LSQ) for your contribution in demonstrating how we support research translation, collaboration and commercialisation. The visit also provided an opportunity for Minister Husic to understand how we are building scale-up biomedical manufacturing capability through construction of our translational manufacturing facility. QUT (Queensland University of Technology) The University of Queensland Mater Research Queensland Health Metro South Health
Visit to TRI by Federal Industry and Science Minister Ed Husic
-
"Getting to be in the lab and actually doing things on my own has made me realise that research could be something I could do..." Students from high schools around South-East Queensland have been inspired to engage with science, engineering and technology during National Science Week. SPARQ-ed welcomed the 50 students to a functioning laboratory at TRI to delve into cell biology and microbiology, as well as meeting researchers and understanding their work. More about SPARQ-ed: https://lnkd.in/gu72YEqD Queensland Department of Education #Scienceweek #NationalScienceWeek #research
National Science Week Ignites Students’ Passion for Research at TRI
-
It was time for networking, knowledge sharing and enjoying each other's company at TRI yesterday, with the monthly morning tea for our early and mid-career researchers. But we also used the occasion to share with our TRI community the expertise and equipment we have as part of our core facilities: flow cytometry, microscopy, proteomics, pre-clinical imaging, biological research facilities and gnotobiotics. Thank you to all who joined the discussion with our core facility managers. QUT (Queensland University of Technology) The University of Queensland Mater Research Queensland Health Metro South Health
-
-
Congratulations, TRI-based Infensa Bioscience, a finalist in the Life Sciences Queensland Ltd (LSQ) GENE Awards in the KE Select - Scientific & Medical Recruitment Specialists Emerging Innovator category. Infensa is developing game-changing therapeutics to reduce the mortality and morbidity associated with heart attack and stroke. The GENE Awards recognise excellence and achievement in Queensland's life sciences sector. Winners will be announced on Friday.
-
-
It is with great pleasure that TRI announces the appointment of eminent cancer researcher and clinician Professor Maher Gandhi as our next CEO. Professor Gandhi is Executive Director of the Institute’s partner, Mater Research, and a Fellow of The Royal Australasian College of Physicians. He will take up the new role in February 2025. "There has never been a more exciting time to lead the Institute,” he says. We would also like to acknowledge Professor Scott Bell for his outstanding leadership, expertise and vision during the past five years as CEO of TRI. Professor Bell has driven meaningful collaborations, research outcomes and scale-up biomedical manufacturing capability through with the construction of our new translational manufacturing facility. Read more: https://lnkd.in/gyQYq4Gg
-
-
Congratulations, TRI CEO Professor Scott Bell, a finalist in the Life Sciences Queensland Ltd (LSQ) GENE Awards in the McCullough Robertson Industry Excellence category. Prof Bell is a respected respiratory physician, leader and mentor who has galvanised meaningful collaboration, supported powerful research outcomes and driven expansion of TRI’s capability with the construction of our new translational manufacturing facility. The GENE Awards recognise excellence and achievement in Queensland's life sciences sector. Winners will be announced on Friday.
-
-
World Sight Day is approaching on October 11 - and the LVF Eye Centre is using the opportunity to host a charity fundraising gala dinner. Proceeds go to Layton Vision Foundation, a charity which supports clinical research at the LVF Ophthalmology Research Centre in the TRI building, with scientists dedicated to curing avoidable blindness through advanced gene therapy research. World Sight Day is an international event that focuses the world’s attention on the importance of good eye health and vision care. https://lnkd.in/gbCQfhjc
-
-
It's almost time for QLD Showcase, the MTPConnect event at TRI on Monday, designed to help accelerate therapeutic development with leading Australian facilities. The event will showcase Australia’s cutting edge national research infrastructure, detail how to access them and other funding opportunities, and explain how other companies used these facilities to advance their therapeutic development to the next stage. Hear from Therapeutic Innovation Australia, Bioplatforms Australia, ANFF Queensland, Phenomics Australia and National Measurement Institute, Australia. Register at https://lnkd.in/grCMYxAi
-
-
Congratulations, TRI-based Dr Nathalie Bock from QUT (Queensland University of Technology), a finalist in the Life Sciences Queensland Ltd (LSQ) GENE Awards for the Rose-Anne Kelso Commemorative Award. Dr Bock is the Leader of the Bone & Tumour Bioengineering research group and the Deputy Co-Director of the Max Planck Queensland Centre (MPQC) for the Materials Science of Extracellular Matrices. Her work includes developing bone metastatic tissue models for individualised therapy guidance in breast cancer. The GENE Awards recognise excellence and achievement in Queensland's life sciences sector. Winners will be announced on August 30.
-